Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Assets Average (2020 - 2025)

Benitec Biopharma (BNTC) has disclosed Assets Average for 6 consecutive years, with $92.1 million as the latest value for Q1 2025.

  • Quarterly Assets Average rose 406.92% to $92.1 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $92.1 million through Mar 2025, up 406.92% year-over-year, with the annual reading at $28.3 million for FY2024, 443.01% up from the prior year.
  • Assets Average hit $92.1 million in Q1 2025 for Benitec Biopharma, up from $73.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $92.1 million in Q1 2025 to a low of $6.3 million in Q2 2023.
  • Historically, Assets Average has averaged $26.4 million across 5 years, with a median of $15.9 million in 2021.
  • Biggest five-year swings in Assets Average: tumbled 53.93% in 2022 and later surged 429.87% in 2024.
  • Year by year, Assets Average stood at $15.9 million in 2021, then dropped by 5.75% to $15.0 million in 2022, then soared by 61.25% to $24.2 million in 2023, then surged by 205.42% to $73.9 million in 2024, then increased by 24.64% to $92.1 million in 2025.
  • Business Quant data shows Assets Average for BNTC at $92.1 million in Q1 2025, $73.9 million in Q4 2024, and $60.5 million in Q3 2024.